Search

Your search keyword '"Francica, Joseph R."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Francica, Joseph R." Remove constraint Author: "Francica, Joseph R."
135 results on '"Francica, Joseph R."'

Search Results

1. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans

2. Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection

3. DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

4. In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

5. 1355. The SARS-CoV-2 Monoclonal Antibody AZD3152 Potently Neutralizes Historical and Emerging Variants and is Being Developed for the Prevention and Treatment of COVID-19 in High-risk Individuals

6. Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

8. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

9. Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

10. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

11. Highly protective antimalarial antibodies via precision library generation and yeast display screening

12. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

13. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

15. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein

16. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

19. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

20. A Monoclonal Antibody for Malaria Prevention

21. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

22. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

23. Functional human IgA targets a conserved site on malaria sporozoites

24. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

25. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

26. Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria

27. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

28. Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

29. AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults

30. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

31. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver

33. Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques

34. Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates

35. Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction

36. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

37. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs

39. LBS technology: Powerful solutions looking for a market. (Location-Based Services)

40. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake

41. Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant

42. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity

43. Longitudinal Antibody Development in SHIVAD8 Infected Non-Human Primate

46. Parasite-dependent cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D-substrate and correlates with protection

49. Are retail attractiveness (Huff) models misused? (Business Geographics)

50. Will 2002 mark the second coming of business geographics? (Business Geographics)

Catalog

Books, media, physical & digital resources